CALO', GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 245
NA - Nord America 109
AS - Asia 74
AF - Africa 5
SA - Sud America 2
Totale 435
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 132
US - Stati Uniti d'America 109
FR - Francia 93
CN - Cina 32
DE - Germania 12
PH - Filippine 11
AE - Emirati Arabi Uniti 10
KR - Corea 8
TR - Turchia 8
ZA - Sudafrica 5
BR - Brasile 2
GB - Regno Unito 2
MY - Malesia 2
SE - Svezia 2
UA - Ucraina 2
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
JP - Giappone 1
SG - Singapore 1
Totale 435
Salva come PNG Salva come JPEG
Città #
Padova 77
Beijing 27
Agordo 26
Paris 15
Ashburn 12
Los Angeles 10
Bay 9
Istanbul 8
Seoul 6
Cedar Knolls 5
Chicago 5
Columbus 5
Milan 4
Pretoria 4
Seattle 4
Atlanta 3
Buffalo 3
New York 3
Roslindale 3
Arlington 2
Bristol 2
Böblingen 2
Chuncheon 2
Düsseldorf 2
Ferrara 2
Frigole 2
Henderson 2
Jequié 2
Kota Kinabalu 2
Lecco 2
Lithonia 2
Livermore 2
Matelica 2
Miami 2
Minalin 2
North Brunswick 2
Santa Clara 2
Turin 2
Venice 2
Bellevue 1
Berlin 1
Bolzano 1
Brunflo 1
Camerino 1
Castelraimondo 1
Catania 1
Cesenatico 1
Codroipo 1
Council Bluffs 1
Crugers 1
Dallas 1
Dulles 1
Edison 1
Federal Way 1
Florence 1
Forlì 1
Grenoble 1
Guangzhou 1
Helsinki 1
Herndon 1
Houston 1
Johannesburg 1
Las Vegas 1
Legnaro 1
Lincoln 1
London 1
Minamicho 1
Nashville 1
Pasadena 1
Pescara 1
Reston 1
Samarinda 1
San Francisco 1
Totale 303
Salva come PNG Salva come JPEG
Nome #
NOP receptor pharmacological profile – A dynamic mass redistribution study, file e14fb26e-9149-3de1-e053-1705fe0ac030 87
The Insect Type 1 Tyramine Receptors: From Structure to Behavior, file e14fb26e-545a-3de1-e053-1705fe0ac030 48
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists, file e14fb26e-a9f8-3de1-e053-1705fe0ac030 24
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism, file e14fb26e-a476-3de1-e053-1705fe0ac030 22
Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus, file 1a5b7085-583d-4037-9eb7-fcd13dcceae5 17
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice, file e14fb26e-4504-3de1-e053-1705fe0ac030 17
In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45, file e14fb26e-8d50-3de1-e053-1705fe0ac030 16
Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuli, file d4b1a701-b1e1-466c-9b14-008033b9f109 15
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo), file e14fb26e-4897-3de1-e053-1705fe0ac030 13
Plant-derived peptides rubiscolin-6, soymorphin-6 and their c-terminal amide derivatives: Pharmacokinetic properties and biological activity, file e14fb26e-4505-3de1-e053-1705fe0ac030 12
In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCP, file e14fb26e-f7b7-3de1-e053-1705fe0ac030 10
MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands, file e14fb26f-6057-3de1-e053-1705fe0ac030 10
Functional selectivity of EM-2 analogs at the mu-opioid receptor, file c607593a-e875-45b0-8dee-462a2ff63204 9
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors, file 2f219c8c-d1ad-4bab-b596-2e92ea44dd44 8
In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells, file 8d216eda-785d-435f-ad0d-1b76a20ff115 8
Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review, file e14fb26e-a475-3de1-e053-1705fe0ac030 8
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands, file e14fb270-1e2a-3de1-e053-1705fe0ac030 8
Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors, file e14fb26e-59b7-3de1-e053-1705fe0ac030 7
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands, file e14fb26e-6eea-3de1-e053-1705fe0ac030 7
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides, file e14fb26e-9252-3de1-e053-1705fe0ac030 7
Circadian variation in attempted suicide by deliberate self-poisoning, file e14fb26e-966a-3de1-e053-1705fe0ac030 7
Functional Profile of Systemic and Intrathecal Cebranopadol in Nonhuman Primates, file e14fb26f-08ef-3de1-e053-1705fe0ac030 7
The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo., file e14fb26e-5460-3de1-e053-1705fe0ac030 6
The concise guide to pharmacology 2019/20: G protein-coupled receptors, file e14fb26e-5c2c-3de1-e053-1705fe0ac030 6
Neuropeptide S-initiated sequential cascade mediated by OX1, NK1, mGlu5 and CB1 receptors: A pivotal role in stress-induced analgesia, file e14fb26e-a76a-3de1-e053-1705fe0ac030 6
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity, file e14fb26e-4479-3de1-e053-1705fe0ac030 5
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials, file e14fb26e-474e-3de1-e053-1705fe0ac030 5
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2, file e14fb26e-6e6d-3de1-e053-1705fe0ac030 5
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics, file e14fb26e-8a86-3de1-e053-1705fe0ac030 5
Nociceptin/orphanin FQ and urinary bladder, file bb2abd51-4fc1-445b-9f7f-cd5c6a0e6a1a 4
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides, file e14fb26e-9253-3de1-e053-1705fe0ac030 4
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist, file fec947ac-0881-4c43-ba64-8c7bf8b4fa5d 4
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors, file e14fb26e-ada6-3de1-e053-1705fe0ac030 3
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040, file e14fb26e-474d-3de1-e053-1705fe0ac030 2
Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults, file e14fb26e-6b99-3de1-e053-1705fe0ac030 2
Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid, file e14fb26e-914c-3de1-e053-1705fe0ac030 2
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus, file e14fb270-4105-3de1-e053-1705fe0ac030 2
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test, file f64f76bc-12cc-4416-a9f9-d564f85d9b91 2
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells, file fa99fea1-07f0-4c97-b4b2-156288255941 2
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress, file e14fb26e-55b0-3de1-e053-1705fe0ac030 1
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders, file e14fb26e-940e-3de1-e053-1705fe0ac030 1
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes, file e14fb26e-abd3-3de1-e053-1705fe0ac030 1
Totale 435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.883
article - articoli 3.860
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 23
Totale 7.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202222 4 0 2 6 2 4 1 2 0 0 1 0
2022/2023103 5 4 0 9 9 11 13 7 17 9 14 5
2023/2024310 7 0 2 4 24 51 33 95 69 16 9 0
Totale 435